Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Capital Expenditures (2022 - 2025)

Historic Capital Expenditures for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $5.2 million.

  • Prokidney's Capital Expenditures rose 11618.14% to $5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.0 million, marking a year-over-year increase of 52729.72%. This contributed to the annual value of $29.5 million for FY2024, which is 1370.88% down from last year.
  • As of Q3 2025, Prokidney's Capital Expenditures stood at $5.2 million, which was up 11618.14% from $3.1 million recorded in Q2 2025.
  • Prokidney's Capital Expenditures' 5-year high stood at $27.9 million during Q3 2023, with a 5-year trough of $306000.0 in Q4 2022.
  • Over the past 4 years, Prokidney's median Capital Expenditures value was $1.1 million (recorded in 2025), while the average stood at $5.0 million.
  • Per our database at Business Quant, Prokidney's Capital Expenditures skyrocketed by 876952.38% in 2023 and then crashed by 9139.55% in 2024.
  • Over the past 4 years, Prokidney's Capital Expenditures (Quarter) stood at $306000.0 in 2022, then surged by 413.73% to $1.6 million in 2023, then surged by 1522.71% to $25.5 million in 2024, then tumbled by 79.63% to $5.2 million in 2025.
  • Its Capital Expenditures stands at $5.2 million for Q3 2025, versus $3.1 million for Q2 2025 and $1.1 million for Q1 2025.